Transcriptomic analysis of cell envelope inhibition by prodigiosin in methicillin-resistant Staphylococcus aureus

Methicillin-resistant Staphylococcus aureus (MRSA) is a leading threat to public health as it is resistant to most currently available antibiotics. Prodigiosin is a secondary metabolite of microorganisms with broad-spectrum antibacterial activity. This study identified a significant antibacterial ef...

Full description

Bibliographic Details
Main Authors: Xiaoxia Liu, Zonglin Wang, Zhongyu You, Wei Wang, Yujie Wang, Wenjing Wu, Yongjia Peng, Suping Zhang, Yinan Yun, Jin Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2024.1333526/full
_version_ 1797349401802309632
author Xiaoxia Liu
Zonglin Wang
Zonglin Wang
Zhongyu You
Wei Wang
Yujie Wang
Wenjing Wu
Yongjia Peng
Suping Zhang
Yinan Yun
Jin Zhang
author_facet Xiaoxia Liu
Zonglin Wang
Zonglin Wang
Zhongyu You
Wei Wang
Yujie Wang
Wenjing Wu
Yongjia Peng
Suping Zhang
Yinan Yun
Jin Zhang
author_sort Xiaoxia Liu
collection DOAJ
description Methicillin-resistant Staphylococcus aureus (MRSA) is a leading threat to public health as it is resistant to most currently available antibiotics. Prodigiosin is a secondary metabolite of microorganisms with broad-spectrum antibacterial activity. This study identified a significant antibacterial effect of prodigiosin against MRSA with a minimum inhibitory concentration as low as 2.5 mg/L. The results of scanning electron microscopy, crystal violet staining, and confocal laser scanning microscopy indicated that prodigiosin inhibited biofilm formation in S. aureus USA300, while also destroying the structure of the cell wall and cell membrane, which was confirmed by transmission electron microscopy. At a prodigiosin concentration of 1.25 mg/L, biofilm formation was inhibited by 76.24%, while 2.5 mg/L prodigiosin significantly reduced the vitality of MRSA cells in the biofilm. Furthermore, the transcriptomic results obtained at 1/8 MIC of prodigiosin indicated that 235and 387 genes of S. aureus USA300 were significantly up- and downregulated, respectively. The downregulated genes were related to two-component systems, including the transcriptional regulator LytS, quorum sensing histidine kinases SrrB, NreA and NreB, peptidoglycan biosynthesis enzymes (MurQ and GlmU), iron-sulfur cluster repair protein ScdA, microbial surface components recognizing adaptive matrix molecules, as well as the key arginine synthesis enzymes ArcC and ArgF. The upregulated genes were mainly related to cell wall biosynthesis, as well as two-component systems including vancomycin resistance-associated regulator, lipoteichoic acid biosynthesis related proteins DltD and DltB, as well as the 9 capsular polysaccharide biosynthesis proteins. This study elucidated the molecular mechanisms through which prodigiosin affects the cell envelope of MRSA from the perspectives of cell wall synthesis, cell membrane and biofilm formation, providing new potential targets for the development of antimicrobials for the treatment of MRSA.
first_indexed 2024-03-08T12:29:23Z
format Article
id doaj.art-8dea091a195c4aa5bbc3847ac1124dab
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-03-08T12:29:23Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-8dea091a195c4aa5bbc3847ac1124dab2024-01-22T04:46:32ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2024-01-011510.3389/fmicb.2024.13335261333526Transcriptomic analysis of cell envelope inhibition by prodigiosin in methicillin-resistant Staphylococcus aureusXiaoxia Liu0Zonglin Wang1Zonglin Wang2Zhongyu You3Wei Wang4Yujie Wang5Wenjing Wu6Yongjia Peng7Suping Zhang8Yinan Yun9Jin Zhang10College of Biological, Chemical Sciences and Engineering, Jiaxing University, Jiaxing, ChinaCollege of Biological, Chemical Sciences and Engineering, Jiaxing University, Jiaxing, ChinaCollege of Geography and Environmental Sciences, Zhejiang Normal University, Jinhua, ChinaCollege of Biological, Chemical Sciences and Engineering, Jiaxing University, Jiaxing, ChinaClinical Laboratory of First Hospital of Jiaxing, Jiaxing, ChinaCollege of Biological, Chemical Sciences and Engineering, Jiaxing University, Jiaxing, ChinaCollege of Biological, Chemical Sciences and Engineering, Jiaxing University, Jiaxing, ChinaCollege of Biological, Chemical Sciences and Engineering, Jiaxing University, Jiaxing, ChinaCollege of Advanced Materials Engineering, Jiaxing Nanhu University, Jiaxing, ChinaCollege of Biological, Chemical Sciences and Engineering, Jiaxing University, Jiaxing, ChinaCollege of Biological, Chemical Sciences and Engineering, Jiaxing University, Jiaxing, ChinaMethicillin-resistant Staphylococcus aureus (MRSA) is a leading threat to public health as it is resistant to most currently available antibiotics. Prodigiosin is a secondary metabolite of microorganisms with broad-spectrum antibacterial activity. This study identified a significant antibacterial effect of prodigiosin against MRSA with a minimum inhibitory concentration as low as 2.5 mg/L. The results of scanning electron microscopy, crystal violet staining, and confocal laser scanning microscopy indicated that prodigiosin inhibited biofilm formation in S. aureus USA300, while also destroying the structure of the cell wall and cell membrane, which was confirmed by transmission electron microscopy. At a prodigiosin concentration of 1.25 mg/L, biofilm formation was inhibited by 76.24%, while 2.5 mg/L prodigiosin significantly reduced the vitality of MRSA cells in the biofilm. Furthermore, the transcriptomic results obtained at 1/8 MIC of prodigiosin indicated that 235and 387 genes of S. aureus USA300 were significantly up- and downregulated, respectively. The downregulated genes were related to two-component systems, including the transcriptional regulator LytS, quorum sensing histidine kinases SrrB, NreA and NreB, peptidoglycan biosynthesis enzymes (MurQ and GlmU), iron-sulfur cluster repair protein ScdA, microbial surface components recognizing adaptive matrix molecules, as well as the key arginine synthesis enzymes ArcC and ArgF. The upregulated genes were mainly related to cell wall biosynthesis, as well as two-component systems including vancomycin resistance-associated regulator, lipoteichoic acid biosynthesis related proteins DltD and DltB, as well as the 9 capsular polysaccharide biosynthesis proteins. This study elucidated the molecular mechanisms through which prodigiosin affects the cell envelope of MRSA from the perspectives of cell wall synthesis, cell membrane and biofilm formation, providing new potential targets for the development of antimicrobials for the treatment of MRSA.https://www.frontiersin.org/articles/10.3389/fmicb.2024.1333526/fullprodigiosinmethicillin-resistant Staphylococcus aureusbiofilmtranscriptomic analysismolecular mechanism
spellingShingle Xiaoxia Liu
Zonglin Wang
Zonglin Wang
Zhongyu You
Wei Wang
Yujie Wang
Wenjing Wu
Yongjia Peng
Suping Zhang
Yinan Yun
Jin Zhang
Transcriptomic analysis of cell envelope inhibition by prodigiosin in methicillin-resistant Staphylococcus aureus
Frontiers in Microbiology
prodigiosin
methicillin-resistant Staphylococcus aureus
biofilm
transcriptomic analysis
molecular mechanism
title Transcriptomic analysis of cell envelope inhibition by prodigiosin in methicillin-resistant Staphylococcus aureus
title_full Transcriptomic analysis of cell envelope inhibition by prodigiosin in methicillin-resistant Staphylococcus aureus
title_fullStr Transcriptomic analysis of cell envelope inhibition by prodigiosin in methicillin-resistant Staphylococcus aureus
title_full_unstemmed Transcriptomic analysis of cell envelope inhibition by prodigiosin in methicillin-resistant Staphylococcus aureus
title_short Transcriptomic analysis of cell envelope inhibition by prodigiosin in methicillin-resistant Staphylococcus aureus
title_sort transcriptomic analysis of cell envelope inhibition by prodigiosin in methicillin resistant staphylococcus aureus
topic prodigiosin
methicillin-resistant Staphylococcus aureus
biofilm
transcriptomic analysis
molecular mechanism
url https://www.frontiersin.org/articles/10.3389/fmicb.2024.1333526/full
work_keys_str_mv AT xiaoxialiu transcriptomicanalysisofcellenvelopeinhibitionbyprodigiosininmethicillinresistantstaphylococcusaureus
AT zonglinwang transcriptomicanalysisofcellenvelopeinhibitionbyprodigiosininmethicillinresistantstaphylococcusaureus
AT zonglinwang transcriptomicanalysisofcellenvelopeinhibitionbyprodigiosininmethicillinresistantstaphylococcusaureus
AT zhongyuyou transcriptomicanalysisofcellenvelopeinhibitionbyprodigiosininmethicillinresistantstaphylococcusaureus
AT weiwang transcriptomicanalysisofcellenvelopeinhibitionbyprodigiosininmethicillinresistantstaphylococcusaureus
AT yujiewang transcriptomicanalysisofcellenvelopeinhibitionbyprodigiosininmethicillinresistantstaphylococcusaureus
AT wenjingwu transcriptomicanalysisofcellenvelopeinhibitionbyprodigiosininmethicillinresistantstaphylococcusaureus
AT yongjiapeng transcriptomicanalysisofcellenvelopeinhibitionbyprodigiosininmethicillinresistantstaphylococcusaureus
AT supingzhang transcriptomicanalysisofcellenvelopeinhibitionbyprodigiosininmethicillinresistantstaphylococcusaureus
AT yinanyun transcriptomicanalysisofcellenvelopeinhibitionbyprodigiosininmethicillinresistantstaphylococcusaureus
AT jinzhang transcriptomicanalysisofcellenvelopeinhibitionbyprodigiosininmethicillinresistantstaphylococcusaureus